UBS Completes Initial Live Transaction of Tokenized Fund Utilizing Chainlink Standard
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 04 2025
0mins
Should l Buy UBS?
UBS's Tokenized Fund Workflow: UBS has successfully completed the world's first end-to-end tokenized fund workflow using Chainlink's Digital Transfer Agent standard, involving the on-chain subscription and redemption of its proprietary uMINT token on the Ethereum blockchain.
Role of DigiFT: In this transaction, DigiFT acted as the on-chain fund distributor, facilitating the process and showcasing the potential for secure and compliant workflows for tokenized assets in institutional finance.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy UBS?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on UBS
Wall Street analysts forecast UBS stock price to rise
11 Analyst Rating
7 Buy
2 Hold
2 Sell
Moderate Buy
Current: 43.230
Low
39.12
Averages
52.09
High
71.73
Current: 43.230
Low
39.12
Averages
52.09
High
71.73
About UBS
UBS Group AG is a Switzerland-based holding company and conducts its operations through UBS AG and its subsidiaries. The company operates as a wealth manager with focused asset management and investment banking capabilities and a capital-light and cash-generative business model. The Company comprises four business divisions: Global Wealth Management, which provides tailored advice and solutions to its clients around the globe; Personal & Corporate Banking division provides comprehensive financial products and services to private, corporate and institutional clients in Switzerland; Asset Management division offers investment capabilities and styles across all traditional and alternative asset classes, as well as advisory support to institutions; Investment Bank provides investment advice, financial solutions and capital markets access to institutional, corporate and wealth management clients.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Iran's Attack in Strait of Hormuz Drives Oil Prices Higher
- Oil Price Surge: Brent crude prices jumped over 3% to around $102 a barrel by Wednesday afternoon, while WTI rose over 4% to more than $93 a barrel, reflecting the market's sensitivity to geopolitical tensions in the region.
- Impact of Strait Closure: The closure of the Strait of Hormuz results in a daily loss of 10 to 15 million barrels of oil globally, with 20% of liquefied natural gas supplies also choked off, indicating severe long-term damage to the oil market and the global economy.
- Optimistic Outlook for Oil Companies: Despite oil prices rising over 50%, shares of major oil companies like Chevron and ConocoPhillips have only increased by 22% and 31% respectively, suggesting that if conflict reignites, these firms could see significantly higher stock prices due to their low-cost operations.
- Future Cash Flow Expectations: Chevron anticipates generating an additional $12.5 billion in free cash flow this year at $70 oil, while ConocoPhillips' projections will also rise significantly, indicating that oil companies' financial health will improve further in a high oil price environment.
See More
Iran Attacks Ships in Strait of Hormuz, Oil Prices Surge
- Oil Price Surge: Following Iran's attacks on ships in the Strait of Hormuz, Brent crude prices jumped over 3% to around $102 per barrel, while WTI prices rose over 4% to more than $93, reflecting market concerns over supply disruptions.
- Supply Chain Risks: The closure of the Strait of Hormuz results in a daily loss of 10 to 15 million barrels of oil globally, with 20% of liquefied natural gas supplies affected, posing significant long-term risks to the global economy.
- Oil Company Outlook: Despite the surge in oil prices, major oil companies like Chevron and ConocoPhillips have seen more modest stock gains of 22% and 31%, respectively, but could benefit significantly from low-cost operations if conflicts escalate.
- Future Projections: UBS anticipates that Brent crude will remain above $90 even with a peace deal, suggesting ongoing volatility in the oil market that could fuel further gains in oil stocks, prompting investor interest in potential share buyback plans.
See More
Swiss Government Adjusts UBS Capital Requirements
- Capital Requirement Adjustment: The Swiss government proposed that UBS Group must strengthen its common equity tier 1 (CET1) capital by approximately $20 billion, easing earlier requirements, which reflects a responsiveness to market feedback and may alleviate capital pressure on UBS.
- CET1 Ratio Expectations: Following the implementation of the new measures, UBS's CET1 capital ratio is projected to be 15.5%, an increase from the current 14%, aligning with international peers and potentially boosting market confidence in UBS's financial stability.
- Company's Opposition to Proposal: Despite the government's adjustments, UBS continues to strongly oppose the proposal, arguing that it is extreme and lacks international alignment, asserting that its adoption would have far-reaching consequences for the Swiss economy, indicating the company's dissatisfaction with the regulatory environment.
- Net Capital Impact Assessment: UBS estimates that the amendments will result in a net CET1 capital impact of about $2 billion, bringing the total impact of the proposals to $22 billion, reflecting the company's adaptability to capital requirements and the potential implications for its future financial health.
See More
UBS Upgrades Biogen, Sees 21% Upside Potential
- Rating Upgrade: UBS has upgraded Biogen's rating from neutral to buy and raised its price target from $185 to $225, indicating a potential 21% upside, reflecting optimism about the company's future performance.
- Market Outperformance: Biogen has gained nearly 6% year-to-date in 2026, outperforming the broader market, although its stock still trades at a discount compared to the S&P 500 healthcare sector, highlighting its undervalued potential.
- Pipeline Catalysts: The investigational Alzheimer's treatment BIIB080 is set for clinical studies this summer, with analysts predicting positive results could boost the stock by 10-25%, enhancing market confidence.
- Upcoming Data Releases: The company will release phase-three trial data for its lupus drug litifilimab in Q4, and positive results could lead to a stock increase of over 20%, supporting its commercial growth trajectory.
See More
UBS Analysis: Impact of US-Iran Ceasefire on Stocks
- Ceasefire Impact Assessment: UBS analysts evaluated individual stocks' performance during the US-Iran ceasefire using three metrics, including exposure to Middle Eastern commodities, pricing power, and sensitivity to past supply shocks, providing investors with clear investment directions.
- Southwest Airlines Outlook: The stock of Southwest Airlines fell over 25% during the war, but UBS believes it will benefit if hostilities cease; prior to the conflict, analysts upgraded the stock to buy, anticipating that new initiatives would enhance profitability.
- Procter & Gamble Potential Winner: As of Monday, Procter & Gamble's stock was 14% below its pre-war level, despite gaining 17% in the first two months of the year, and UBS sees potential for recovery and increased market confidence if peace is achieved.
- UPS Growth Opportunities: UPS's stock rose 17% in the two months before the war but fell 18% during hostilities; UBS analysts noted that avoiding further conflict could benefit UPS due to its undervalued stock and potential earnings growth.
See More
Analysis of Growth Potential for Chainlink Token LINK
- Token Performance Review: Chainlink's native token LINK launched at $0.11 in 2017 and currently trades around $9.30, translating a $10,000 investment into nearly $1.7 million, although it remains below its record high of $52.99 from May 2021.
- Decentralized Network Functionality: As a decentralized 'oracle' network, Chainlink connects blockchains to real-world data, ensuring developers can access real-time information like weather and stock prices through smart contracts, thereby enhancing the utility of blockchain applications.
- Node Operator Incentive Mechanism: Independent node operators earn LINK tokens by providing data and can stake these as collateral to earn interest-like rewards; however, intentionally feeding false data can lead to confiscation of their tokens and damage to their reputation scores.
- Financial Partnership Expansion: Over the past year, Chainlink has partnered with 24 major financial institutions, including UBS and SWIFT, to modernize traditional financial systems, and this expansion could significantly increase the value of LINK tokens as it plays a crucial role in bridging traditional finance and blockchain networks.
See More
Iran's Attack in Strait of Hormuz Drives Oil Prices Higher
- Oil Price Surge: Brent crude prices jumped over 3% to around $102 a barrel by Wednesday afternoon, while WTI rose over 4% to more than $93 a barrel, reflecting the market's sensitivity to geopolitical tensions in the region.
- Impact of Strait Closure: The closure of the Strait of Hormuz results in a daily loss of 10 to 15 million barrels of oil globally, with 20% of liquefied natural gas supplies also choked off, indicating severe long-term damage to the oil market and the global economy.
- Optimistic Outlook for Oil Companies: Despite oil prices rising over 50%, shares of major oil companies like Chevron and ConocoPhillips have only increased by 22% and 31% respectively, suggesting that if conflict reignites, these firms could see significantly higher stock prices due to their low-cost operations.
- Future Cash Flow Expectations: Chevron anticipates generating an additional $12.5 billion in free cash flow this year at $70 oil, while ConocoPhillips' projections will also rise significantly, indicating that oil companies' financial health will improve further in a high oil price environment.
See More
Iran Attacks Ships in Strait of Hormuz, Oil Prices Surge
- Oil Price Surge: Following Iran's attacks on ships in the Strait of Hormuz, Brent crude prices jumped over 3% to around $102 per barrel, while WTI prices rose over 4% to more than $93, reflecting market concerns over supply disruptions.
- Supply Chain Risks: The closure of the Strait of Hormuz results in a daily loss of 10 to 15 million barrels of oil globally, with 20% of liquefied natural gas supplies affected, posing significant long-term risks to the global economy.
- Oil Company Outlook: Despite the surge in oil prices, major oil companies like Chevron and ConocoPhillips have seen more modest stock gains of 22% and 31%, respectively, but could benefit significantly from low-cost operations if conflicts escalate.
- Future Projections: UBS anticipates that Brent crude will remain above $90 even with a peace deal, suggesting ongoing volatility in the oil market that could fuel further gains in oil stocks, prompting investor interest in potential share buyback plans.
See More
Swiss Government Adjusts UBS Capital Requirements
- Capital Requirement Adjustment: The Swiss government proposed that UBS Group must strengthen its common equity tier 1 (CET1) capital by approximately $20 billion, easing earlier requirements, which reflects a responsiveness to market feedback and may alleviate capital pressure on UBS.
- CET1 Ratio Expectations: Following the implementation of the new measures, UBS's CET1 capital ratio is projected to be 15.5%, an increase from the current 14%, aligning with international peers and potentially boosting market confidence in UBS's financial stability.
- Company's Opposition to Proposal: Despite the government's adjustments, UBS continues to strongly oppose the proposal, arguing that it is extreme and lacks international alignment, asserting that its adoption would have far-reaching consequences for the Swiss economy, indicating the company's dissatisfaction with the regulatory environment.
- Net Capital Impact Assessment: UBS estimates that the amendments will result in a net CET1 capital impact of about $2 billion, bringing the total impact of the proposals to $22 billion, reflecting the company's adaptability to capital requirements and the potential implications for its future financial health.
See More
UBS Upgrades Biogen, Sees 21% Upside Potential
- Rating Upgrade: UBS has upgraded Biogen's rating from neutral to buy and raised its price target from $185 to $225, indicating a potential 21% upside, reflecting optimism about the company's future performance.
- Market Outperformance: Biogen has gained nearly 6% year-to-date in 2026, outperforming the broader market, although its stock still trades at a discount compared to the S&P 500 healthcare sector, highlighting its undervalued potential.
- Pipeline Catalysts: The investigational Alzheimer's treatment BIIB080 is set for clinical studies this summer, with analysts predicting positive results could boost the stock by 10-25%, enhancing market confidence.
- Upcoming Data Releases: The company will release phase-three trial data for its lupus drug litifilimab in Q4, and positive results could lead to a stock increase of over 20%, supporting its commercial growth trajectory.
See More
UBS Analysis: Impact of US-Iran Ceasefire on Stocks
- Ceasefire Impact Assessment: UBS analysts evaluated individual stocks' performance during the US-Iran ceasefire using three metrics, including exposure to Middle Eastern commodities, pricing power, and sensitivity to past supply shocks, providing investors with clear investment directions.
- Southwest Airlines Outlook: The stock of Southwest Airlines fell over 25% during the war, but UBS believes it will benefit if hostilities cease; prior to the conflict, analysts upgraded the stock to buy, anticipating that new initiatives would enhance profitability.
- Procter & Gamble Potential Winner: As of Monday, Procter & Gamble's stock was 14% below its pre-war level, despite gaining 17% in the first two months of the year, and UBS sees potential for recovery and increased market confidence if peace is achieved.
- UPS Growth Opportunities: UPS's stock rose 17% in the two months before the war but fell 18% during hostilities; UBS analysts noted that avoiding further conflict could benefit UPS due to its undervalued stock and potential earnings growth.
See More
Analysis of Growth Potential for Chainlink Token LINK
- Token Performance Review: Chainlink's native token LINK launched at $0.11 in 2017 and currently trades around $9.30, translating a $10,000 investment into nearly $1.7 million, although it remains below its record high of $52.99 from May 2021.
- Decentralized Network Functionality: As a decentralized 'oracle' network, Chainlink connects blockchains to real-world data, ensuring developers can access real-time information like weather and stock prices through smart contracts, thereby enhancing the utility of blockchain applications.
- Node Operator Incentive Mechanism: Independent node operators earn LINK tokens by providing data and can stake these as collateral to earn interest-like rewards; however, intentionally feeding false data can lead to confiscation of their tokens and damage to their reputation scores.
- Financial Partnership Expansion: Over the past year, Chainlink has partnered with 24 major financial institutions, including UBS and SWIFT, to modernize traditional financial systems, and this expansion could significantly increase the value of LINK tokens as it plays a crucial role in bridging traditional finance and blockchain networks.
See More
